THE COURSE OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH COVID-19

In a pandemic situation caused by a coronavirus infection, a special risk group is made up of patients with cardiovascular diseases, which are often found in the population. The co-occurrence of these diseases increases the risk of adverse effects. Caring for these patients requires physicians to be aware of the characteristics of the viral infection, its clinical presentation, the events that occur in association with cardiovascular disease, and individual and collective protection measures. The safety of medical personnel and a good prognosis for patients is one of the highest values of the modern healthcare system. Arrhythmias , myocarditis and heart failure are not only typical clinical manifestations of coronavirus infection, but also occupy a prominent place in the structure of mortality. The problem is exacerbated by the potential cardiotoxicity and arrhythmogenicity of a number of drugs prescribed for the treatment of COVID-19. All this requires maximum cardiac vigilance in the treatment of patients with COVID-19, timely use of echocardiography, ECG, control of biomarkers of myocardial damage and stress, as well as pathogenetically justified prescription of cardiotonic and cardioprotective drugs.

Hali tarjima qilinmagan